Comella, P. et al. 2010. Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet. Acta Oncologica. 49, 1 (Jan. 2010), 50–56. DOI:https://doi.org/10.3109/02841860903369540.